Search

everythinglearnresearchcommunity

for

Search:↓

Hydrangea serrata extract may promote hair growth and improve hair health.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Melanocytes are important for normal body functions and have potential uses in regenerative medicine and disease treatment.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

The mTurq2-Col4a1 mouse model shows how the basement membrane develops in live mammals.

Targeting lipid metabolism can help treat advanced, resistant cancers.

The conclusion is that accurately replicating the complexity of the extracellular matrix in the lab is crucial for creating realistic human tissue models.

The research identified key molecules that help hair matrix and dermal papilla cells communicate and influence hair growth in cashmere goats.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

A man with a rare scalp cancer was successfully treated, highlighting the need for early management to prevent spread and complications.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

A 70-year-old woman with a malignant adrenal tumor improved after surgery and radiotherapy.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

The conclusion is that Pigmented Epithelioid Melanocytoma can start from hair follicle stem cells or from a mole on the skin.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Saw palmetto extract may help treat brain tumors by blocking a specific growth signal and blood vessel formation.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.